Specialty Pharmaceutical Company with a Focus in Pain and Addiction

« Back

Document Details

Form
Filing Date
Mar 1, 2019
Document Date
Mar 1, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC

Investor Presentation

There are no items to display.

Get the latest details on our products and services.

SIGN UP